Posted: Oct 24, 2016 8:44 am
by Macdoc
Each cancer type is different and there are wide ranging types of treatment depending on the spread. Each patient is different as well.

Brain tumours rarely end well as there are blood brain barriers that pose problems to chemo, radiation is difficult and surgery often both damaging and misses some

The reason I'm pissed with bullshit doled out in this thread is that early diagnosis is absolutely vital and the meme being presented here is exactly the type of crap thinking that Jobs and others have bought into - leaving it too late for successful treatment.

The issue is rife in some indigene communities where an easily cured childhood leukemia gets "treated" with voodoo crap and turns into later stage with poorer outcomes.

Chemo is not one treatment is myriad of treatments that are designed specifically to each patient.
It is not always successful and the success rate is dependent on the cancer type, the patient and how advanced. It moves forward all the time.

The cancer I had showed much better outcomes once Rituxamab was added to CHOP to make CHOPR
Drugs in the CHOP combination:
C = Cyclophosphamide
H = Doxorubicin Hydrochloride (Hydroxydaunomycin)
O = Vincristine Sulfate (Oncovin)
P = Prednisone
Chemotherapy is often given as a combination of drugs. Combinations usually work better than single drugs because different drugs kill cancer cells in different ways.

But despite a high success rate was in no way a sure thing.

The ONLY people that can guide you is a trained oncologist - there is a deluge of new approaches and some experimental treatments that show promise. Their reading on the subject has to be daily...there is so much change ...and that varies with each cancer type.
Some like breast cancer still do not have desirable success rates...others like childhood lukemia and mine ...non-Hodkins lymphoma have improved dramatically.

Since once in three women and one in two men will confront personl cancer in their lifetime s critical people do not buy into voodoo nonsense.

Two of three Australians will confront skin cancer in their lives. Usually easily treated early - it can kill if ignored.

New approaches that are universal are to hyper activate the immune system - as it's really the only approach to wide spread cancer where chemo and surgery options ae exhausted...

Steve Cara expected to sail through the routine medical tests required to increase his life insurance in October 2014. But the results were devastating. He had lung cancer, at age 53. It had begun to spread, and doctors told him it was inoperable.

A few years ago, they would have suggested chemotherapy. Instead, his oncologist, Dr. Matthew D. Hellmann of Memorial Sloan Kettering Cancer Center in New York, recommended an experimental treatment: immunotherapy. Rather than attacking the cancer directly, as chemo does, immunotherapy tries to rally the patient’s own immune system to fight the disease.

Uncertain, Mr. Cara sought a second opinion. A doctor at another major hospital read his scans and pathology report, then asked what Dr. Hellmann had advised. When the doctor heard the answer, Mr. Cara recalled, “he closed up the folder, handed it back to me and said, ‘Run back there as fast as you can.’ ... .html?_r=0

Chemotherapy is only one tool in cancer treatment's hard on the body due to how it works. There are reactions to it that can be deadly for few - stats show somewhere froom 1-3% mortality for chemo patients from the chemo itself.

here's authority on chemo and recent stats from a very broad base....

Main findings

Most of the people who died within 30 days were receiving palliative treatment (where the cancer cannot be cured and chemotherapy is given to relieve symptoms and improve quality of life): 569 breast cancer patients and 720 lung cancer patients.

There were also a small number of deaths in those patients given treatment with the intention to cure: 41 breast cancer patients and 53 lung cancer patients.

There were no clusters of these deaths. The majority of hospitals had no curative intent deaths at all; those deaths were scattered across 53 different Trusts (just under half of the total).

Older patients with more advanced disease, who also had other illnesses and a worse performance status, were more likely to die.

Patients with a high body mass index (BMI) were less likely to die than those with a low BMI.

Patients were most likely to die when being given their first round of chemotherapy.

Early death rates from clinical trials in the treatment of non-small cell lung cancer with curative intent are around 0.8%.


Chemotherapy is a vital part of cancer treatment and is a large reason behind the improved survival rates over last 4 decades.
However, it is powerful medication with significant side effects and often getting the balance right on which patients to treat aggressively can be hard. Studies like this help improve our understanding of how people are affected by chemotherapy in the real world and most importantly help us to treat patients better. ... ancer-data

Aggie - send your friend the NYT article.